Evidence map›Paper›PMID 27511006›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2016

Compartment-Dependent Degradation of Mutant Huntingtin Accounts for Its Preferential Accumulation in Neuronal Processes.

Ting Zhao, Yan Hong, Shihua Li, Xiao-Jiang Li

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
2.3field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 47 citations in OpenAlex.

  1. Review
  2. The mCells · 2025
    Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Vitamin B3 Biotech · 2023
    Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Deletion of SUMO1 attenuates behavioral and anatomical deficits by regulating autophagic activities in Huntington disease.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  13. Review
  14. Altered Cholesterol Homeostasis in Huntington's Disease.Frontiers in aging neuroscience · 2022
    Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 2 countries.

Ting ZhaoDepartment of Human Genetics, Emory University School of Medicine, Atlanta, Georgia 30322, and.ORCID 0000-0002-9630-8290
Yan HongDepartment of Human Genetics, Emory University School of Medicine, Atlanta, Georgia 30322, and.ORCID 0000-0002-7315-0814
Shihua LiDepartment of Human Genetics, Emory University School of Medicine, Atlanta, Georgia 30322, and sli@emory.edu xli2@emory.edu.
Xiao-Jiang LiDepartment of Human Genetics, Emory University School of Medicine, Atlanta, Georgia 30322, and State Key Laboratory of Molecular Developmental Biology, Institute of Genetics and Developmental Biology, Chinese Academy of Sciences, Chaoyang District, Beijing 100101, China sli@emory.edu xli2@emory.edu.ORCID 0000-0003-1775-6536
Emory University · US

Funding

Neuronal function of huntingtin-associated proteinR01NS036232 · NINDS · EMORY UNIVERSITY · PI ESCAYG, ANDREW P · 1998 to 2021
$6.7M
Nuclear Toxicity of Huntington Disease ProteinR01NS041669 · NINDS · EMORY UNIVERSITY · PI LI, XIAO-JIANG · 2001 to 2015
$4.6M
Synaptic toxicity of Huntington disease proteinR01AG019206 · NIA · EMORY UNIVERSITY · PI LI, XIAO-JIANG · 2001 to 2016
$4.5M
Polyglutamine expansion and neuropathologyR01NS045016 · NINDS · EMORY UNIVERSITY · PI LI, SHI-HUA · 2004 to 2013
$2.9M
Glial huntingtin and neurodegenerationR01NS095181 · NINDS · EMORY UNIVERSITY · PI WEINSHENKER, DAVID · 2015 to 2019
$1.7M
Polyglutamine Expansion Length Dependent PathologyR01NS095279 · NINDS · EMORY UNIVERSITY · PI WARREN, STEPHEN T. · 2015 to 2019
$1.7M
Glial huntingtin and neuronal excitotoxicityR01AG031153 · NIA · EMORY UNIVERSITY · PI LI, SHI-HUA · 2009 to 2013
$1.5M
Synaptic accumulation of misfolded proteins and neurodegenerationR56AG019206 · NIA · EMORY UNIVERSITY · PI JIN, PENG · 2018 to 2018
$489k
NIA NIH HHS R01 AG019206NIA NIH HHS R01 AG031153NIA NIH HHS R56 AG019206NINDS NIH HHS R01 NS036232NINDS NIH HHS R01 NS041669NINDS NIH HHS R01 NS045016NINDS NIH HHS R01 NS095181NINDS NIH HHS R01 NS095279
6 · The paper itself

Abstract

unlabelledIn neurodegenerative diseases caused by misfolded proteins, including Huntington's disease (HD), the neuronal processes and terminals are particularly prone to the accumulation of misfolded proteins, leading to axonal and synaptic dysfunction. This compartment-dependent accumulation can result from either the altered transport of misfolded proteins or impaired protein degradation. Mutant huntingtin (mHtt), the HD protein, is known to affect intracellular transport and can be degraded by the proteasome and autophagy, but how mHtt accumulates in the neuronal processes, an early pathological event in the brains of HD patients, still remains unclear. Using an "optical pulse-chase" assay that can quantify protein degradation in specific subcellular regions, we found that neuronal mHtt is removed faster in the cell body than in neurites. Furthermore, mHtt is cleared more rapidly in astrocytes than in neurons. The ubiquitin-proteasome system plays a much bigger role than autophagy in degrading soluble mHtt via K48 ubiquitination in both the cytoplasm and processes of neurons and astrocytes. By injecting adenoviral vectors expressing mHtt into the mouse brain, we confirmed that mHtt is removed more slowly in neurites than in the cytoplasm of the cell body of neurons. Our findings provide evidence for the cell type- and compartment-dependent degradation of mHtt and explain why mHtt preferentially accumulates and aggregates in the neuropils of vulnerable neurons. In addition, our findings suggest that enhancing proteasomal activity could be an effective way to reduce the preferential accumulation of soluble mHtt in neuronal processes. SIGNIFICANCE STATEMENT: The clearance of misfolded proteins is key to preventing neurodegeneration in Huntington's disease, but how mutant huntingtin (mHtt) accumulates differentially in different cell types and subcellular regions remains unclear. We found mHtt is cleared slowly in neuronal processes compared with the cytoplasm and is cleared more efficiently in astrocytes than in neurons. Moreover, this compartment-dependent degradation of soluble mHtt is mediated primarily by the ubiquitin-proteasome system rather than autophagy. Our findings imply that enhancing proteasome activity could be an efficient way to clear soluble misfolded proteins in the neuronal processes.

Indexed as

ProteolysisAnimalsAnimals, NewbornBrainCells, CulturedFemaleGlial Fibrillary Acidic ProteinHuntingtin ProteinLuminescent ProteinsMaleMiceMutationNeuronsOptogeneticsPhosphopyruvate HydrataseStatistics, NonparametricDendra2 protein, DendronephthyaGlial Fibrillary Acidic ProteinHuntingtin ProteinLuminescent ProteinsPhosphopyruvate HydrataseSynapsinsUbiquitinclearancedegradationmisfoldingneurodegenerationpolyglutaminesubcellular

Identifiers

PMID27511006
PMCPMC4978797
OpenAlexW2497712933

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.